Literature DB >> 16478754

Selective increases in the cytokine, TNFalpha, in the prefrontal cortex of PCP-treated rats and human schizophrenic subjects: influence of antipsychotic drugs.

G J Paterson1, Y Ohashi, G P Reynolds, J A Pratt, B J Morris.   

Abstract

The psychotomimetic drug phencyclidine (PCP) induces symptoms closely related to those of schizophrenia in humans. In order to test the hypothesis that cytokines may be involved in the aetiology and treatment of schizophrenia, this study investigated the levels of cytokine mRNAs in rat brain after acute and chronic administration of PCP, in the presence and absence of antipsychotic drugs. The levels of the mRNAs encoding TNF, IL-2, IL-6, TGF 1, 2, 3, IL-3 and GM-CSF were measured in the prefrontal cortex, cortex, hippocampus, ventral and dorsal striatum regions of male hooded Long Evans rats after acute drug administration. Antipsychotic drugs and PCP significantly reduced the levels of TNF in the prefrontal cortex compared to vehicle-treated animals, whilst other cytokines remained unchanged. In addition, significant reductions in the levels of TNF mRNA in the prefrontal cortex still occurred 24h after acute PCP administration. However, levels of TNF mRNA were restored to control values after chronic PCP treatment, whereas increased expression was detected in animals co-administered with haloperidol. Levels of TNF mRNA were also found to be significantly increased in the prefrontal cortex of schizophrenic subjects. The relationship between TNF levels and schizophrenia are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16478754     DOI: 10.1177/0269881106062025

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  10 in total

1.  A Study of TNF Pathway Activation in Schizophrenia and Bipolar Disorder in Plasma and Brain Tissue.

Authors:  Eva Zsuzsanna Hoseth; Thor Ueland; Ingrid Dieset; Rebecca Birnbaum; Joo Heon Shin; Joel Edward Kleinman; Thomas Michael Hyde; Ragni Helene Mørch; Sigrun Hope; Tove Lekva; Aurelija Judita Abraityte; Annika E Michelsen; Ingrid Melle; Lars Tjelta Westlye; Torill Ueland; Srdjan Djurovic; Pål Aukrust; Daniel R Weinberger; Ole Andreas Andreassen
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

2.  Clozapine protects dopaminergic neurons from inflammation-induced damage by inhibiting microglial overactivation.

Authors:  Xiaoming Hu; Hui Zhou; Dan Zhang; Sufen Yang; Li Qian; Hung-Ming Wu; Po-See Chen; Belinda Wilson; Hui-Ming Gao; Ru-band Lu; Jau-Shyong Hong
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-26       Impact factor: 4.147

3.  Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims.

Authors:  Ghanshyam N Pandey; Hooriyah S Rizavi; Xinguo Ren; Jawed Fareed; Debra A Hoppensteadt; Rosalinda C Roberts; Robert R Conley; Yogesh Dwivedi
Journal:  J Psychiatr Res       Date:  2011-09-08       Impact factor: 4.791

4.  Harpagophytum Procumbens Ethyl Acetate Fraction Reduces Fluphenazine-Induced Vacuous Chewing Movements and Oxidative Stress in Rat Brain.

Authors:  Larissa Finger Schaffer; Catiuscia Molz de Freitas; Ana Paula Chiapinotto Ceretta; Luis Ricardo Peroza; Elizete de Moraes Reis; Bárbara Nunes Krum; Alcindo Busanello; Aline Augusti Boligon; Jéssie Haigert Sudati; Roselei Fachinetto; Caroline Wagner
Journal:  Neurochem Res       Date:  2016-01-06       Impact factor: 3.996

5.  Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia.

Authors:  M Margarita Behrens; Sameh S Ali; Laura L Dugan
Journal:  J Neurosci       Date:  2008-12-17       Impact factor: 6.167

Review 6.  The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders.

Authors:  Trevor W Stone; L Gail Darlington
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

Review 7.  Rare and very rare adverse effects of clozapine.

Authors:  Pasquale De Fazio; Raffaele Gaetano; Mariarita Caroleo; Gregorio Cerminara; Francesca Maida; Antonio Bruno; Maria Rosaria Muscatello; Maria Jose Jaén Moreno; Emilio Russo; Cristina Segura-García
Journal:  Neuropsychiatr Dis Treat       Date:  2015-08-06       Impact factor: 2.570

8.  The reduction of CSF tumor necrosis factor alpha levels in schizophrenia: no correlations with psychopathology and coincident metabolic characteristics.

Authors:  Haibing Zhu; Danfeng Wang; Xiuqin Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2016-11-03       Impact factor: 2.570

9.  Haloperidol Abrogates Matrix Metalloproteinase-9 Expression by Inhibition of NF-κB Activation in Stimulated Human Monocytic Cells.

Authors:  Yueh-Lun Lee; Che-Jen Hsiao; Fan-Li Lin; Jing-Shiun Jan; Yung-Chen Chou; Yen-Yu Lin; Chih-Kuang Chen; Kwok-Keung Lam; George Hsiao
Journal:  Mediators Inflamm       Date:  2018-04-12       Impact factor: 4.711

10.  Novel alternatively-spliced exons of the VRK2 gene in mouse brain and microglial cells.

Authors:  Salsabil Almarzooq; Jaedeok Kwon; Ashleigh Willis; John Craig; Brian J Morris
Journal:  Mol Biol Rep       Date:  2020-06-24       Impact factor: 2.316

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.